Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > Question ???
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(571)
•••
Comment by mdjbrownon Jun 21, 2024 6:09pm
75 Views
Post# 36100950

RE:RE:RE:RE:RE:Question ???

RE:RE:RE:RE:RE:Question ???It would be nice if the folks at Medipharm updated shareholders with regards to the following clinical study, as initially it was promoted that Labs was supplying the CBD for this study.


https://clinicaltrials.gov/study/NCT06206291
 
https://www.mountsinai.org/clinical-trials/cannabidiol-for-opioid-addiction


International Clinical Trial with Renowned Researcher: In May 2019, it was announced that New York City’s Icahn School of Medicine at Mount Sinai Hospital and renowned global researcher Dr. Yasmin Hurd, had selected MediPharm Labs to partner on a major Clinical Research Study and “CBD International Consortium” to develop treatment of Opioid Addiction.MediPharm Labs would provide CBD gelcaps for more than 500 patients involved in the study with test sites in Canada, the USA, Jamaica, Australia and Europe. This commitment to medical cannabis research dovetailed with MediPharm Labs long term vision of being an active pharmaceutical ingredient provider to makers of cannabis medicines.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities